Brief: Cytek Biosciences Q2 Revenue USD 46.617 Million Vs. IBES Estimate USD 49.5 Million
06/08/2024 21:05
Aug 06 (Reuters) - Cytek Biosciences Q2 pretax profit USD -7.186 million. * Q2 adjusted EBITDA USD 2.947 million * Q2 adjusted gross margin 58% * Q2 net income USD -10.434 million * outlook FY revenue USD 203-210 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million